LAB vs PAYC · rev $174.4M vs P/E 33, rev $1.88B
Standard Biotools Inc (LAB) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Paycom Soft (PAYC) is a software - application company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported PAYC revenue for 2024-12-31 was $1.88B. Net income was $502.0M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
LAB currently screens at market cap $317.1M. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the LAB and PAYC stock pages for the full models.
Not investment advice.